CLColgate-Palmolive Company
Colgate-Palmolive has one year to prove it can sustain its recent momentum — the Q3 2026 earnings release on 2026-10-30 is the first test, with the stock expected to anchor at $90.79 and swing to a bull target of $95.95 or a bear fallback of $86.66. The next step is a bull tilt, but the path is clear: the company must deliver consistent performance across its core brands, navigate macroeconomic headwinds, and show resilience in a sector that’s been battered by inflation and shifting consumer behavior. If it clears this hurdle, the next catalysts — Q4 2026, Q1 2027, and Q2 2027 — will be the next tests in a sequence that could push the stock toward $113.00 or back toward $102.24, depending on how the company performs in each quarter.
The Read
9% due to macroeconomic headwinds and volatility, remained flat on in-line Q1 2026 results, and traded flat on mixed Q2 performance despite beating Base Business EPS, with median moves of ~7%.
The schedule
- Wed9Sep
The Colgate-Palmolive webcast is an important communication event where the company will discuss its strategic initiatives and business outlook. These webcasts often provide valuable insights into the company's long-term plans and operational performance, which can influence investor confidence and stock valuation. The event is expected to generate positive sentiment based on past performance, which could lead to a favorable price movement in the days following the webcast. This event, while not as impactful as an earnings report, still holds significance for market participants looking to gauge the company's direction.
- Fri30Oct
The Q3 2026 earnings release is a key event where Colgate-Palmolive will disclose its quarterly financial results, including revenue and earnings per share guidance. This report is expected to provide insight into the company's performance during the third quarter and its outlook for the remainder of the year. The outcome of this event could significantly impact the stock price, given the high level of market attention and the importance of earnings reports in shaping investor sentiment. Investors should closely monitor the actual results compared to expectations, as this will influence the stock's direction in the following weeks.
- Tue9Feb
The Q4 2026 earnings release is a major event where Colgate-Palmolive will present its fourth-quarter financial results, including revenue and earnings per share guidance. This report is critical for assessing the company's performance for the full year and its ability to meet or exceed expectations. The outcome of this event is likely to have a substantial impact on the stock price, given the high level of market interest and the importance of year-end earnings in shaping investor sentiment. Investors should pay close attention to the actual results and any management commentary, as this will influence the stock's trajectory in the weeks ahead.
- Fri23Apr
- Fri30Jul
Past
- Fri31Jul
Actual outcome: Mixed · $92.53 at outcome
Colgate-Palmolive delivered a mixed Q2 report, beating Base Business EPS estimates with $0.99 per share and posting 4.9% net sales growth driven by strong margins and Latin American performance. However, the stock traded flat as the company merely reaffirmed its annual sales forecast amid softer category trends, elevated competition, and weak consumer demand in North America.
Colgate-Palmolive delivered a mixed Q2 report, beating Base Business EPS estimates with $0.99 per share and posting 4.9% net sales growth driven by strong margins and Latin American performance. However, the stock traded flat as the company merely reaffirmed its annual sales forecast amid softer category trends, elevated competition, and weak consumer demand in North America.
- Thu30Apr
Actual outcome: Bull · $88.16 at outcome
Colgate-Palmolive reported Q1 2026 earnings that exactly met analyst expectations, delivering an EPS of -$0.046. The stock remained flat as the perfectly in-line results reflected a balance between the company's pricing power and premiumization efforts against ongoing cost pressures and weak volumes.
Colgate-Palmolive reported Q1 2026 earnings that exactly met analyst expectations, delivering an EPS of -$0.046. The stock remained flat as the perfectly in-line results reflected a balance between the company's pricing power and premiumization efforts against ongoing cost pressures and weak volumes.
- Sun1Mar
Actual outcome: Bear · $85.73 at outcome
While Colgate-Palmolive was highlighted as a resilient dividend aristocrat, the stock fell well below the bear floor of $94.00 by the run date due to significant macroeconomic headwinds. A 36% surge in WTI crude oil prices and rising market volatility (VIX up 29%) intensified
While Colgate-Palmolive was highlighted as a resilient dividend aristocrat, the stock fell well below the bear floor of $94.00 by the run date due to significant macroeconomic headwinds. A 36% surge in WTI crude oil prices and rising market volatility (VIX up 29%) intensified
- Mon23Feb
Actual outcome: Bull · $94.88 at outcome
Colgate-Palmolive delivered a strong Q4 2025 earnings beat (EPS $0.95 vs. $0.912 estimate), driven by robust pricing power and resilient global demand, particularly in emerging markets. The stock rallied significantly because the results confirmed improving momentum and strong operational execution, addressing investor focus on margin recovery and organic sales growth. The better-than-expected Q4 performance and record cash flow reinforced investor confidence in the company's trajectory, pushing the stock well past the $86.50 bull target.
Colgate-Palmolive delivered a strong Q4 2025 earnings beat (EPS $0.95 vs. $0.912 estimate), driven by robust pricing power and resilient global demand, particularly in emerging markets. The stock rallied significantly because the results confirmed improving momentum and strong operational execution, addressing investor focus on margin recovery and organic sales growth. The better-than-expected Q4 performance and record cash flow reinforced investor confidence in the company's trajectory, pushing the stock well past the $86.50 bull target.
Scouting Reports
The LNG Supercycle: How WMB and Cheniere Toll the Export Boom
Sep 8, 2026
The energy security narrative has quietly transitioned from frantic winter bidding wars to decades-long concrete pours. Overnight, Korean media reported that Seoul and the United States agreed on a ma
Read more →
The Thermal Bottleneck: Pricing the Liquid Cooling Cycle
Aug 27, 2026
The physical limits of standard data center architecture are finally colliding with the ambition of next-generation silicon. For two decades, cooling a server farm was a brute-force exercise in moving
Read more →
Pricing the Pharma Patent Cliff: The AI Biotech Outsourcing Trade
Aug 25, 2026
The latest breakthrough in personalized cancer treatments isn’t just a win for oncology—it is the opening bell for a massive capital reallocation. Staring down a catastrophic wave of late-2020s patent
Read more →